Is it rash to use unlisted new crown vaccine in emergency? Official response

category:Finance
 Is it rash to use unlisted new crown vaccine in emergency? Official response


He revealed that in the process of promoting the emergency use of the new crown vaccine, China has carried out a very strict expert demonstration and optimized the emergency use vaccine. Chinas emergency use of vaccines is strictly in accordance with the relevant provisions of all animal experiments and clinical phase I, II experiments, and phase I, II experiments have also achieved very good safety indicators and immunogenicity indicators. In addition, prior to the official launch of the emergency use of the new coronal vaccine, the preferred vaccine has been approved for three phases of clinical trials. At present, the large-scale population data of the third phase clinical trial in China once again verified the safety and effectiveness of the new crown vaccine emergency use in China. In addition, in the process of emergency use of new coronal vaccine, our country strictly follows the approved scheme, which is organized and implemented under the premise of voluntary, informed and consent, and has established a very strict screening of vaccinated personnel, monitoring and emergency treatment of adverse reactions, and tracking work program after vaccination. So far, in the process of emergency use of new coronal vaccine in China, no serious adverse reactions have been reported in all personnel, and some people who go to work in high-risk areas have not reported infection. Source: Beijing Daily editor: Yang Bin_ NF4368

In addition, in the process of emergency use of new coronal vaccine, our country strictly follows the approved scheme, which is organized and implemented under the premise of voluntary, informed and consent, and has established a very strict screening of vaccinated personnel, monitoring and emergency treatment of adverse reactions, and tracking work program after vaccination. So far, in the process of emergency use of new coronal vaccine in China, no serious adverse reactions have been reported in all personnel, and some people who go to work in high-risk areas have not reported infection.